Immunotherapy plus chemoradiotherapy in cervical cancer management

Lancet. 2024 Apr 6;403(10434):1310-1311. doi: 10.1016/S0140-6736(24)00468-9. Epub 2024 Mar 20.

Authors

Krishnansu S Tewari¹, Bradley J Monk²

Affiliations

¹ Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of California, Irvine Medical Center, Orange, CA 92868, USA. Electronic address: ktewari@uci.edu.
² Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA.

PMID: 38521084
DOI: 10.1016/S0140-6736(24)00468-9

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Chemoradiotherapy
Cisplatin
Female
Humans
Immunotherapy
Uterine Cervical Neoplasms* / drug therapy

Substances

Cisplatin